Two innovative genetic tests Pill Protect® and Cypass® reimbursed by supplementary insurance
As of November 1st, 2016, Gene Predictis’ genetic tests Pill Protect® and Cypass® are reimbursed by supplementary healthcare cover PRIMEO from Helsana, the leading insurance group in Switzerland. These tests allow to evaluate, for every individual, the risk of adverse drug events by integrating both patient’s genetics and clinical data. This represents a significant step forward towards personalization of care for patients on one hand and preventive medicine on the other.